71
Views
0
CrossRef citations to date
0
Altmetric
Malignancy

Heparin Induces Apoptosis in Lymphocytes from B-cell Chronic Lymphocytic Leukemia

, , , , , , & show all
Pages 451-463 | Received 22 Oct 1998, Published online: 13 Jul 2016

References

  • Reilly, C. F., Kindy, M. S., Brown, K. E., Rosemberg, R. D. and Sonenshein, G. (1989). Heparin prevents vascular smooth muscle progression through the G1 phase of the cell cycle. J. Biol. Chem., 264, 6990–5.
  • Wright, T. C., Pukac, L. A., Castellot, J. J. et al. (1989). Heparin suppress the induction of c-fos amd c-myc mRNA in murine fibroblasts by selective inhibition of a protein kinase C-dependent pathway. PNAS USA, 86, 3199–203.
  • Yang, L. and Yang, Y. C. (1995). Heparin inhibits the expression of the interleukin-11 and granulocyte-macrophage colony-stimulating factor in primate bone marrow stromal fibroblasts through mRNA destabilization. Blood, 86, 2526–33.
  • Manaster, J., Chezar, J., Shurtz-Swirski, R., Shapiro, G., Tendler, Y., Kristal, B., Shasha, S. M. and Sela, S. (1996). Heparin induces apoptosis in human peripheral blood neutrophils. Br. J. Haematol., 94, 48–52.
  • Ihrcke, N. S., Wrenshall, L. E., Lindman, B. J. and Platt, J. (1993). Role of heparan sulfate in immune system blood vessels interactions. Immunol. Today, 14, 500–5.
  • Wrenshall, L. E., Cerra, F. B., Carlson, A., Bach, F. H. and Platt, J. L. (1991). Regulation of murine splenocyte responses by heparan sulfate. J. Immunol., 147, 455–59.
  • Hanada, M., Delia, D., Aiello, A., Stadmauer, E. and Reed, J. (1993). Bc1–2 gene hypomethilation and highlevel expression in B-cell chronic lymphocytic leukemia. Blood, 82, 1820–28.
  • Nicoletti, I., Migliorati, G., Pagliacci, M. C., Grignani, F. and Riccardi, C. (1991). A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staging and flow cytometry. J. Immunol. Meth., 139, 271–79.
  • Poletti, A., Manconi, R. and De Paoli, P. (1988). Double labeling immunohistologic and flow cytometric analysis of human B cells with particular reference to Leu-8 expression. Hum. Path., 19, 1001–7.
  • Dive, C., Gregory, D. G., Phipps, D. L., Evans, D. L., Milner, A. E. and Wullie, A. H. (1992). Analysis and discrimination of necrosis and apoptosis (programmed cell death) by multiparameter flow cytometry. Biochim. Biophys. Acta., 1113, 275–85.
  • McCloskey, T. W., Oyaizu, N., Coronesi, M. and Pahwa, S. (1994). Use of a flow cytometric assay to quantitate apoptosis in human lymphocytes. Clin. Immunol. Immunopathol., 71, 14–8.
  • Schena, M., Larsson, L. G. and Gottardi, D. (1992). Growth and differentiation associated expression of bcl-2 in chronic lymphocytic leukemia cells. Blood, 79, 2981–9.
  • Mackay, C. R. and Imhof, B. A. (1993). Cell adhesion in the immune system. Immunol Today, 14, 99–102.
  • Menzel, T., Rahman, Z., Calleja, E., White, K., Wilson, E. L., Wieder, R. and Gabrilove, J. (1996). Elevated intracellular level of basic fibroblast growth factor correlates with stage of chronic lymphocytic leukemia and is associated with resistance to fludarabine. Blood, 87, 1056–63.
  • König, A., Menzel, T., Lynen, S., Wrazel, L., Rosen, A., Al-Katib, A., Raveche, E. and Gabrilove, J. L. (1997). Basic fibroblast growth factor (bFGF) upregulates the expression of bc1–2 in B-cell chronic lymphocytic leukemia lines resulting in delaying apoptosis. Leukemia, 11, 258–65.
  • Bono, F., Rigon, P., Lamarche, I., Savi, P., Salel, V. and Herbert, J. M. (1997). Heparin inhibits the binding of basic fibroblast growth factor to cultured human aortic smooth-muscle cells. Biochem. J., 326, 661–8.
  • Roghani, M., Mansukhani, A., Dell'Era, P., Bellosta, P., Basilico, C., Rifkin, D. B. and Moscatelli, D. (1994). Heparin increases the affinity of basic fibroblast growth factor for its receptor but is not required for binding. J. Biol. Chem., 296, 3976–84.
  • Faham, S., Hileman, R. E., Fromm, J. R., Linhardt, R. J. and Rees, D. C. (1996). Heparin structure and interactions with basic fibroblast growth factor. Science, 271, 1116–20.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.